3.2(top 5%)
Impact Factor
3.6(top 5%)
extended IF
38(top 10%)
H-Index
368
authors
472
papers
6.2K
citations
1.5K
citing journals
5.2K
citing authors

Most Cited Articles of Therapeutic Advances in Urology

TitleYearCitations
An introduction to the epidemiology and burden of urinary tract infections2019135
Management of iatrogenic ureteral injury2014115
Role of inflammation in bladder function and interstitial cystitis2011115
The Prostate Health Index: a new test for the detection of prostate cancer2014111
Best practice in the treatment of nonmuscle invasive bladder cancer201296
Targeting PD-1/PD-L1 in the treatment of metastatic renal cell carcinoma201590
Oxidation-reduction potential of semen: what is its role in the treatment of male infertility?201684
Biomarkers in prostate cancer surveillance and screening: past, present, and future201379
Contemporary diagnosis and management of Fournier's gangrene201570
Mirabegron: a review of recent data and its prospects in the management of overactive bladder201270
Management of inferior vena cava tumor thrombus in locally advanced renal cell carcinoma201568
Dapoxetine: a new option in the medical management of premature ejaculation201265
The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction201761
Ureteral stents: new ideas, new designs201060
Shockwave treatment of erectile dysfunction201359
Recent developments in the treatment of renal cell carcinoma201357
'Mini, ultra, micro' - nomenclature and cost of these new minimally invasive percutaneous nephrolithotomy (PCNL) techniques201656
The increasing pediatric stone disease problem201156
Malignancy after gastrointestinal augmentation in childhood200954
Management of spermatic cord tumors: a rare urologic malignancy201253
Chronic orchialgia: evaluation and discussion of treatment options201052
Risk factors and predisposing conditions for urinary tract infection201951
Management of priapism: an update for clinicians201449
Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk201546
Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born201246